多个遗传位置影响了在基因多样化的小鼠中疫苗诱导的对Mycobacterium结核病的保护
Sherry L Kurtz1, Richard E Baker2, Frederick J Boehm3
1Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, United States of America.
PLoS pathogens
|March 7, 2024
概括
宿主遗传学影响BCG疫苗对结核病的有效性. 这项研究确定了控制免疫反应的遗传位置,揭示了保护是对新疫苗开发至关重要的多基因特征.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 仍然是全球主要的健康威胁,每年造成超过150万人的死亡.
- 细菌卡尔梅特 - 格林 (BCG) 疫苗接种提供了对渐进性肺结核的可变保护,宿主基因与易感性有关.
- 主体遗传学在调节针对Mycobacterium tuberculosis (M.tb.) 的疫苗反应中的作用. 不是很好地理解.
研究的目的:
- 调查疫苗诱导对M.tb.的保护的遗传基础. 使用小鼠模型感染.
- 确定控制免疫反应和M.tb.的遗传位置. 在BCG疫苗接种后的感染结果.
主要方法:
- 利用多样性异种 (DO) 老鼠,一个遗传多样化的群体,用于定量特征位置 (QTL) 映射.
- 接种BCG疫苗后,接种M.tb.疫苗. 这对大量DO小鼠构成了挑战.
- 经过评估的MTB. 肺部和脏的负担,并在尸体解剖时测量了肺细胞因子概况.
主要成果:
- 确定了与M.tb.相关的16个染色体位点. 感染特征和细胞因子的产生.
- 确认了主要基因相容性抗原和结核病易感性之间的已知关联,验证了QTL映射方法.
- 发现了与M.tb.相关的新型QTL. 免疫反应和细胞因子调节,表明BCG诱导的保护是一种复杂的多基因特征.
结论:
- 宿主基因显著影响BCG疫苗对M.tb.疫苗的有效性. 感染. 感染.
- BCG诱导的保护是多基因的,具有独特的遗传位置影响各种免疫反应组件.
- 通过了解免疫反应的遗传控制,这些发现为开发更有效的结核病疫苗提供了新的目标.
相关概念视频
Mismatch Repair
Overview
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...


